Al-Dawaa Medical Services Company (4163.SR)
SAR 79.0
(1.67%)
SAR 79.0
(1.67%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.3 Billion SAR | 21.1% |
| 2022 | 1.08 Billion SAR | -18.79% |
| 2021 | 1.33 Billion SAR | -14.94% |
| 2020 | 1.56 Billion SAR | 21.21% |
| 2019 | 1.29 Billion SAR | -1.0% |
| 2018 | 1.3 Billion SAR | 7.01% |
| 2017 | 1.21 Billion SAR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.49 Billion SAR | 14.3% |
| 2024 Q2 | 1.49 Billion SAR | -0.11% |
| 2023 Q4 | 1.3 Billion SAR | 3.12% |
| 2023 FY | 1.3 Billion SAR | 21.1% |
| 2023 Q3 | 1.27 Billion SAR | -3.41% |
| 2023 Q2 | 1.31 Billion SAR | -6.35% |
| 2023 Q1 | 1.4 Billion SAR | 29.83% |
| 2022 Q2 | 1.4 Billion SAR | -15.64% |
| 2022 FY | 1.08 Billion SAR | -18.79% |
| 2022 Q4 | 1.08 Billion SAR | -9.24% |
| 2022 Q3 | 1.19 Billion SAR | -15.11% |
| 2022 Q1 | 1.66 Billion SAR | 24.95% |
| 2021 Q1 | - SAR | -100.0% |
| 2021 FY | 1.33 Billion SAR | -14.94% |
| 2021 Q4 | 1.33 Billion SAR | 0.0% |
| 2021 Q2 | 1.35 Billion SAR | 0.0% |
| 2020 Q1 | - SAR | 0.0% |
| 2020 Q3 | 1.32 Billion SAR | 0.0% |
| 2020 Q4 | 1.32 Billion SAR | 0.0% |
| 2020 FY | 1.56 Billion SAR | 21.21% |
| 2019 FY | 1.29 Billion SAR | -1.0% |
| 2018 FY | 1.3 Billion SAR | 7.01% |
| 2017 FY | 1.21 Billion SAR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Middle East Pharmaceutical Industries Co. | 87.17 Million SAR | -1402.417% |
| Nahdi Medical Company | 1.4 Billion SAR | 7.077% |
| Al-Razi Medical Co. | 22.81 Million SAR | -5640.431% |
| Almujtama Alraida Medical Co. | 143.32 Million SAR | -813.798% |